ReviewBritish journal of cancer2016
Hypoxia-activated prodrugs: paths forward in the era of personalised medicine.
Francis W Hunter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
104 papers cite itlatest 60 shown
this paperpooled ittrialcites it